Skip to main content

Tweets

#ACR21 Ab#1166. How many of your pts use marijuana? ⭐️Probably more than you think! ▶️57% have tried, >50% use at least weekly ▶️67% doctors thought <20% of pts use it 🔥Pts over 40 yo MORE likely to report marijuana use @Rheumnow https://t.co/0uW8rZvf1k https://t.co/ShMnR0faHr
Eric Dein @ericdeinmd ( View Tweet )
4 years 8 months ago
#ACR21 #Abstr1461 Post-hoc analyses from BLISS-LN #lupus showed independent of IV Steroid pulses during induction, at Wk104: 💠More pts in Belimumab achieved PERR and CR vs PBO 💠More pts in PBO had flares and kidney event/death vs BEL @RheumNow https://t.co/pLxAI2RDRJ https://t.co/8CZMq3RTls
Md Yuzaiful Md Yusof @Yuz6Yusof ( View Tweet )
4 years 8 months ago
Lianne Gensler presenting "Exercise Strategies for Ankylosing Spondylitis". Not all physical activity is similarly beneficial. Learn more now by attending her session at #ACR21! @CherylKoehn @ArthritisNetwrk @EIM_Canada @exerciseworks @PhysioKTBroker @jwhittak_physio @JasminKMa https://t.co/rER3EdCohO
JointHealth @ACEJointHealth ( View Tweet )
4 years 8 months ago
@rheum_cat I want to run into an ASAS meeting and shout "seronegative spondyoarthropathy"! https://t.co/WkEz5BMttJ
Richard Conway @RichardPAConway ( View Tweet )
4 years 8 months ago
@LianneGensler Is exercise anti-inflammatory? In this study, healthy volunteers were infused with E coli endotoxin 😲 and their TNF levels measured. TNF levels were compared between groups at rest and groups exercising. TNF levels were ⬇ by exercise. #ACR21 https://t.co/Ylw7SQX32y
Rheum Cat @rheum_cat ( View Tweet )
4 years 8 months ago
@rheum_cat @alhkim You're beating @RheumNow, quite impressive @rheum_cat !

LauraCoates @DrLauraCoates ( View Tweet )

4 years 8 months ago
MRI Imaging in RA and SpA: Dr. Sheila Reyes ( @RHEUMarampa) Dr. Sheila Reyes discusses abstracts #0468 and #0469, presented at the #ACR21 annual meeting. https://t.co/MeVia60BNa https://t.co/WRgCifpioQ
Dr. John Cush @RheumNow ( View Tweet )
4 years 8 months ago
#ACR21 #SLE #COVID19 Use of Telemedicine for follow-up of SLE in COVID19 Wait times lower for telemedicine Patient satisfaction higher in telemedicine group More hospitalization, higher switch to in person follow up in telemedicine https://t.co/Y21Vki1uDP
Dr. Laura Lewandowski @LauraLewMad11 ( View Tweet )
4 years 8 months ago
#ACR21 #SLE SLE – Treatment: New Agents, Old Agents Pooled data from 2 phase 3 trials (TULIP 1 and 2) ⏬LLDAS is an attainable T2T endpoint in adult SLE trials ⏬Anifrolumab treatment associated with earlier and more sustained LLDAS in adult SLE https://t.co/bxGlVsJOZC
Dr. Laura Lewandowski @LauraLewMad11 ( View Tweet )
4 years 8 months ago
1) Trial enrollees were likely partial/non responders to MMF at baseline (NIN had clean slate) 2) Unblinding from diarrhea from NIN, likely tilts toward NIN d/t PLBO effect 3) MMF-PLBO may have had dx longer than NIN-PLBO, missed critical early window to affect progression?

Mike Putman @EBRheum ( View Tweet )

4 years 8 months ago
Interesting thoughts from Dr. Distler re:nintedanib & MMF in SSc-ILD Agree we should look into MMF-nintedanib combo, but this graph makes me think MMF > NIN Why would that be? Unlike NIN, MMF pts were NOT randomized, which likely favors NIN for a few (speculative) reasons: https://t.co/ZHBD8x74PM
Mike Putman @EBRheum ( View Tweet )
4 years 8 months ago
ACR Convergence 2021 attendees – join us this evening, Monday, Nov. 8, from 6:00 to 6:30 PM ET, for the virtual #ACR21 Tweet Up! Add to your agenda → https://t.co/lisFBp1scO #RheumTwitter https://t.co/3pO3quH2Sm
American College of Rheumatology @ACRheum ( View Tweet )
4 years 8 months ago
×